Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Immuno-oncology Therapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Immuno-oncology Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Immuno-oncology Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bristol-Myers Squibb
AstraZeneca
Janssen Biotech
Novartis
Spectrum Pharmaceuticals
GlaxoSmithKline
Merck
Sanofi
Roche
Takeda
Amgen
Pfizer
Eli-Lilly
By Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Others
By End-User:
Hospitals
Ambulatory Surgical Center
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Immuno-oncology Therapy Market
-
1.3 Market Segment by Type
-
1.3.1 USA Immuno-oncology Therapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.2 USA Immuno-oncology Therapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027
-
1.3.3 USA Immuno-oncology Therapy Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
1.3.4 USA Immuno-oncology Therapy Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027
-
1.3.5 USA Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Immuno-oncology Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center from 2016 to 2027
-
1.4.3 USA Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Immuno-oncology Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Immuno-oncology Therapy by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.2 Market Size and Growth Rate of Immune Checkpoint Inhibitors
-
3.4.3 Market Size and Growth Rate of Immune System Modulators
-
3.4.4 Market Size and Growth Rate of Cancer Vaccines
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Immuno-oncology Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Immuno-oncology Therapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Immuno-oncology Therapy in Hospitals
-
4.4.2 Market Size and Growth Rate of Immuno-oncology Therapy in Ambulatory Surgical Center
-
4.4.3 Market Size and Growth Rate of Immuno-oncology Therapy in Others
5 Market Analysis by Regions
-
5.1 USA Immuno-oncology Therapy Production Analysis by Regions
-
5.2 USA Immuno-oncology Therapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Immuno-oncology Therapy Landscape Analysis
-
6.1 West USA Immuno-oncology Therapy Landscape Analysis by Major Types
-
6.2 West USA Immuno-oncology Therapy Landscape Analysis by Major End-Users
7 South USA Immuno-oncology Therapy Landscape Analysis
-
7.1 South USA Immuno-oncology Therapy Landscape Analysis by Major Types
-
7.2 South USA Immuno-oncology Therapy Landscape Analysis by Major End-Users
8 Middle West USA Immuno-oncology Therapy Landscape Analysis
-
8.1 Middle West USA Immuno-oncology Therapy Landscape Analysis by Major Types
-
8.2 Middle West USA Immuno-oncology Therapy Landscape Analysis by Major End-Users
9 Northeast USA Immuno-oncology Therapy Landscape Analysis
-
9.1 Northeast USA Immuno-oncology Therapy Landscape Analysis by Major Types
-
9.2 Northeast USA Immuno-oncology Therapy Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Bristol-Myers Squibb
-
10.1.1 Bristol-Myers Squibb Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 AstraZeneca
-
10.2.1 AstraZeneca Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Janssen Biotech
-
10.3.1 Janssen Biotech Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Novartis
-
10.4.1 Novartis Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Spectrum Pharmaceuticals
-
10.5.1 Spectrum Pharmaceuticals Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 GlaxoSmithKline
-
10.6.1 GlaxoSmithKline Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Merck
-
10.7.1 Merck Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Sanofi
-
10.8.1 Sanofi Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Roche
-
10.9.1 Roche Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Takeda
-
10.10.1 Takeda Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
-
10.11 Amgen
-
10.11.1 Amgen Company Profile and Recent Development
-
10.11.2 Market Performance
-
10.11.3 Product and Service Introduction
-
10.12 Pfizer
-
10.12.1 Pfizer Company Profile and Recent Development
-
10.12.2 Market Performance
-
10.12.3 Product and Service Introduction
-
10.13 Eli-Lilly
-
10.13.1 Eli-Lilly Company Profile and Recent Development
-
10.13.2 Market Performance
-
10.13.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Immune System Modulators from 2016 to 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Ambulatory Surgical Center from 2016 to 2027
-
Figure USA Immuno-oncology Therapy Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Immuno-oncology Therapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Immuno-oncology Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Immuno-oncology Therapy
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Immuno-oncology Therapy by Different Types from 2016 to 2027
-
Table Consumption Share of Immuno-oncology Therapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Immune Checkpoint Inhibitors
-
Figure Market Size and Growth Rate of Immune System Modulators
-
Figure Market Size and Growth Rate of Cancer Vaccines
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Immuno-oncology Therapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Immuno-oncology Therapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Ambulatory Surgical Center
-
Figure Market Size and Growth Rate of Others
-
Table USA Immuno-oncology Therapy Production by Regions
-
Table USA Immuno-oncology Therapy Production Share by Regions
-
Figure USA Immuno-oncology Therapy Production Share by Regions in 2016
-
Figure USA Immuno-oncology Therapy Production Share by Regions in 2021
-
Figure USA Immuno-oncology Therapy Production Share by Regions in 2027
-
Table USA Immuno-oncology Therapy Consumption by Regions
-
Table USA Immuno-oncology Therapy Consumption Share by Regions
-
Figure USA Immuno-oncology Therapy Consumption Share by Regions in 2016
-
Figure USA Immuno-oncology Therapy Consumption Share by Regions in 2021
-
Figure USA Immuno-oncology Therapy Consumption Share by Regions in 2027
-
Table West USA Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table West USA Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure West USA Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure West USA Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure West USA Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table West USA Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table West USA Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure West USA Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure West USA Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table South USA Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table South USA Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure South USA Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure South USA Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure South USA Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table South USA Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table South USA Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure South USA Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure South USA Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Middle West USA Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table Middle West USA Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure Middle West USA Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure Middle West USA Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table Middle West USA Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure Middle West USA Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure Middle West USA Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Northeast USA Immuno-oncology Therapy Consumption by Types from 2016 to 2027
-
Table Northeast USA Immuno-oncology Therapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Immuno-oncology Therapy Consumption Share by Types in 2016
-
Figure Northeast USA Immuno-oncology Therapy Consumption Share by Types in 2021
-
Figure Northeast USA Immuno-oncology Therapy Consumption Share by Types in 2027
-
Table Northeast USA Immuno-oncology Therapy Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Immuno-oncology Therapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Immuno-oncology Therapy Consumption Share by End-Users in 2016
-
Figure Northeast USA Immuno-oncology Therapy Consumption Share by End-Users in 2021
-
Figure Northeast USA Immuno-oncology Therapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Janssen Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Biotech
-
Figure Sales and Growth Rate Analysis of Janssen Biotech
-
Figure Revenue and Market Share Analysis of Janssen Biotech
-
Table Product and Service Introduction of Janssen Biotech
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Spectrum Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spectrum Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Spectrum Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Spectrum Pharmaceuticals
-
Table Product and Service Introduction of Spectrum Pharmaceuticals
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Eli-Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli-Lilly
-
Figure Sales and Growth Rate Analysis of Eli-Lilly
-
Figure Revenue and Market Share Analysis of Eli-Lilly
-
Table Product and Service Introduction of Eli-Lilly
-
